Added to YB: 2024-03-22
Pitch date: 2024-01-23
NTRA [bullish]
Natera, Inc.
+204.01%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.0B
Pitch Price
$67.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-110.32
P/E
-119.45
EV/Sales
10.85
Sector
Biotechnology
Category
growth
Show full summary:
Next Century Growth Investors SMID Cap Growth Strategy New Portfolio holding: Natera, Inc.
NTRA: Leader in cell-free DNA tests for oncology, women's & organ health. Signatera leads in fast-growing MRD testing. Panorama (NIPT) & Prospera also key. Yrs of investment now driving strong revs & nearing cash flow+. Personalized genetic testing moving to standard of care.
Read full article (1 min)